Quality of life, long-term survivors and long-term outcome from the ABC-02 study.
View/ Open
Date
2016-04ICR Author
Author
Bridgewater, J
Lopes, A
Palmer, D
Cunningham, D
Anthoney, A
Maraveyas, A
Madhusudan, S
Iveson, T
Valle, J
Wasan, H
Type
Journal Article
Metadata
Show full item recordAbstract
Background The ABC-02 (Advanced Biliary Tract Cancer) study established cisplatin and gemcitabine (CisGem) as the standard first-line chemotherapy for patients with locally advanced or metastatic biliary tract cancer (BTC). We examine quality of life (QoL), describe the long-term survivors and provide a long-term outcome.Methods A total of 410 BTC patients were randomised to receive either CisGem or gemcitabine alone (Gem); 324 patients consented to complete EORTC QLQ-C30 and EORTC QLQ-PAN26 QoL questionnaires; 268 (83%) patients returned at least one QoL questionnaire (134 in each arm). Long-term survivors were defined as those surviving over 2 years and we performed a final analysis of the primary outcome; overall survival (OS).Results Most QoL scales showed a trend favouring the combined CisGem arm, including functional and symptomatic scales, although the differences were not statistically significant. Forty-five (11%)) patients survived at least 2 years (34 received CisGem and 11 Gem) and 21 (5%) 3 years or more (14 received CisGem and 7 Gem). After a median follow-up of 9.2 months and 398 deaths, the median OS was 11.7 months for CisGem and 8.1 months for Gem (hazard ratio (HR)=0.65, 95% CI: 0.53-0.79, P<0.001).Conclusions The survival advantage of CisGem compared to Gem was not associated with an improvement or deterioration of QoL. Long-term survivors were more likely to have received CisGem and the long-term OS is identical to that previously described.
Collections
Subject
Humans
Biliary Tract Neoplasms
Treatment Outcome
Quality of Life
Survivors
Female
Male
Research team
Medicine (RMH Smith Cunningham)
Language
eng
Date accepted
2016-02-16
License start date
2016-04
Citation
British journal of cancer, 2016, 114 (9), pp. 965 - 971